Storage and Stability of GLP-1 Peptides in the Laboratory

GLP-1 receptor agonists used in research — including Semaglutide and related analogs — are acylated peptides whose long-acting pharmacology depends on intact fatty-acid linker chemistry. Proper laboratory storage is essential to maintaining peptide integrity for reproducible in vitro and animal-model work.

Lyophilized storage. Sealed vials of lyophilized GLP-1 analogs are most stable at −20 °C or below in a non-frost-free freezer. The lyophilizate is protected from hydrolytic and oxidative degradation in the dry state. Studies on semaglutide stability indicate the lyophilized form remains within HPLC-defined specifications for 24+ months under recommended conditions [1].

Reconstituted solution storage. Once reconstituted in bacteriostatic water, GLP-1 analogs are most stable at 2-8 °C. Refrigerated reconstituted Semaglutide retains potency for at least 6 weeks based on accelerated-stability HPLC studies [2]. Repeated freeze-thaw cycles should be avoided; the lipid-anchor architecture is susceptible to aggregation upon thermal cycling.

Light protection. Tryptophan residues in GLP-1-family peptides are photosensitive. Store reconstituted vials wrapped in foil or in opaque containers. Photo-oxidation of Trp produces N-formylkynurenine, which can be detected by characteristic UV absorbance shifts in stability-indicating HPLC methods [3].

Aggregation risk. GLP-1 peptides can form fibrillar aggregates at the air-liquid interface under agitation. Avoid vortexing reconstituted vials; mix by gentle inversion. Aggregation is monitored in stability studies by size-exclusion HPLC and dynamic light scattering [4].

Aliquot strategy. For long-term work, aliquot the reconstituted stock into low-binding polypropylene tubes in single-use volumes and store at −80 °C. This minimizes freeze-thaw exposure of the working stock.

Researchers conducting GLP-1R pharmacology studies can source a research-grade Semaglutide (GLP1) vial from Frontier Peptide Labs, supplied lyophilized with third-party HPLC purity reports for laboratory research use only.

References

1. Lau J, et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. J Med Chem. 2015;58(18):7370-80. DOI: 10.1021/acs.jmedchem.5b00726
2. Manning MC, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. DOI: 10.1007/s11095-009-0045-6
3. Kerwin BA, Remmele RL. Protect from light: photodegradation and protein biologics. J Pharm Sci. 2007;96(6):1468-1479. DOI: 10.1002/jps.20815
4. Wang W. Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm. 2005;289(1-2):1-30. DOI: 10.1016/j.ijpharm.2004.11.014